Jushi Holdings (JUSHF) Enterprise Value (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Enterprise Value came in at -$39.7 million in Q1 2026, down 54.71% year-on-year from -$87.7 million in Q1 2025, and down 65.1% on a QoQ basis from -$24.0 million in Q4 2025.
Jushi Holdings (JUSHF) Enterprise Value (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Enterprise Value data on file, last reported at -$39.7 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 54.71% year-over-year to -$39.7 million in Q1 2026; TTM through Mar 2026 was -$39.7 million, a 54.71% decrease from a year earlier, with the FY2025 full-year figure at -$24.0 million, down 23.19% from the prior year.
- Enterprise Value for Q1 2026 stood at -$39.7 million, down from -$24.0 million in the prior quarter.
- Over the last five years, Enterprise Value for JUSHF reached as high as -$19.5 million in Q4 2024 and fell as low as -$44.6 million in Q2 2022.
- Historically, Enterprise Value has averaged -$28.4 million across 5 years, with a median of -$28.6 million in 2022.
- Across the five-year window, Enterprise Value jumped 71.37% in 2022 and sank 54.71% in 2026, its largest moves.
- Year by year, Enterprise Value stood at -$27.6 million in 2022, then decreased by 10.73% to -$30.5 million in 2023, then jumped by 36.08% to -$19.5 million in 2024, then slipped by 23.19% to -$24.0 million in 2025, then tumbled by 65.1% to -$39.7 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$39.7 million in Q1 2026, -$24.0 million in Q4 2025, and -$23.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | -39.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.70 Mn |
| Dec 31, 2025 | -24.05 Mn |
| Sep 30, 2025 | -23.17 Mn |
| Jun 30, 2025 | -22.91 Mn |
| Mar 31, 2025 | -25.66 Mn |
| Dec 31, 2024 | -19.52 Mn |
| Sep 30, 2024 | -20.74 Mn |
| Jun 30, 2024 | -32.88 Mn |
| Mar 31, 2024 | -29.80 Mn |
| Dec 31, 2023 | -30.54 Mn |
| Sep 30, 2023 | -29.71 Mn |
| Jun 30, 2023 | -31.30 Mn |
| Mar 31, 2023 | -19.86 Mn |
| Dec 31, 2022 | -27.58 Mn |
| Sep 30, 2022 | -32.45 Mn |
| Jun 30, 2022 | -44.57 Mn |
| Dec 31, 2021 | -96.35 Mn |